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Evaluation of Clinical Metrology Instrument in Dogs with
Osteoarthritis
C. Muller, B. Gaines, M. Gruen, B. Case, K. Arrufat, J. Innes, and B.D.X. Lascelles
Background: In veterinary clinical pain studies, there is a paucity of data on test-retest variability in Clinical Metrology
Instruments (CMIs), and it is unknown whether CMIs should be administered using independent (respondents not permitted
to see previous answers) or dependent (respondents shown previous answers) interviewing.
Objectives: To compare baseline variability in CMIs designed to assess pain in dogs with osteoarthritis, and compare
CMI scores using independent (InD) and dependent interviewing (DI) for the Canine Brief Pain Inventory (CBPI) and the
Client-Specific Outcome Measures (CSOM).
Animals: Fifty-one client-owned dogs with radiographic evidence of osteoarthritis and associated pain.
Methods: Clinical Metrology Instruments data were collected during 2 randomized, double-masked, placebo-controlled,
proof of principle pilot studies with parallel treatment groups. Enrolled dogs received either placebo or antinerve growth fac-
tor antibody (NV-01).
Results: Agreement between baseline CMI scores was good (CBPI Pain P = .29, CBPI Interference P = .32, CSOM
P = .036, LOAD P = .67, HCPI P = .27), being best for the LOAD (ICC = 0.89). CMI responses collected during indepen-
dent and dependent interviewing were not statistically different (CBPI Pain P = .33, CBPI Interference P = .28, CSOM
P = .42) and showed good agreement. Additionally, dependent interviewing resulted in increased treatment effect sizes.
Conclusions and Clinical Importance: There is little difference between independent and dependent interviewing, however,
dependent interviewing resulted in increased treatment effect sizes. By using dependent interviewing, investigators could
increase clinical trial power through minimal change to study design. Further research is warranted to investigate the use of
dependent interviewing.
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In veterinary medicine, performing clinical trials thatuse subjective measures provide a unique challenge,
in that completion of these measures requires a proxy
assessment of the animal. In many cases, this is done
using a clinical metrology instrument (CMI), also
referred to as a questionnaire. The use of a proxy to
determine the effect of an intervention (be it a drug or
surgical method) is complicated by many factors that
can introduce bias, and also the inherent variability
from one pet owner to another.1–5 Therefore, using
valid questionnaires and administering them in an
appropriate manner is essential in decreasing variability6
and confounding factors,1,7 and providing accurate
results.
A large body of work has been performed evaluating
the psychology behind how a respondent answers a
questionnaire. Overall, this work demonstrates that
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small, seemingly innocuous changes to a questionnaire
or the manner in which it is presented can drastically
change the results.8 Factors such as how the question-
naire is presented,2,9 how the questionnaire is writ-
ten1,10, and even what type of paper the questionnaire
is printed on7 have all been determined to have an
effect.
Bias has been defined as a deviation of results or
inferences from the truth.11 One form of bias is the fak-
ing bad bias (also known as the hello-goodbye effect),
where respondents try to appear sick to qualify for sup-
port.3,12 In reference to pain studies within veterinary
medicine, respondents could indicate higher impairment
scores so as to gain entry for their pet into the clinical
study. Once on the study, respondents often then revert
to a “more true” representation of their pet’s impair-
ment. Additionally, dogs may tend to be recruited to a
clinical study when the clinical signs are obvious, and
natural variation in the disease causes them to become
less affected as the study starts. These 2 phenomena are
likely partly responsible for the placebo effect. However,
most studies have shown good repeatability (test-retest)
for the validated CMIs used to assess pain and
mobility.13–15
Another form of bias seen specifically in independent
interviewing is called the seam bias.16 Seam bias is
defined as an overrepresentation of change, when mea-
sured across a “seam” between 2 successive survey
administrations and is a unique bias seen in indepen-
dent interviewing (InD) during longitudinal panel sur-
veys.17,18 Subsequent work showed that dependent
interviewing (DI), allowing respondents to review their
previous answers, was more effective in controlling seam
bias and therefore resulted in a more accurate collection
of data.16,18
In most instances, veterinary clinical studies are
designed to not allow respondents to view their previ-
ous answers, a technique termed “independent inter-
viewing.”19 The argument for this technique has
traditionally been that it provides a less biased view of
the current status of their pet, and more accurate
assessments will be obtained. However, by showing
respondents their original answers during the retest
phase, or using “dependent interviewing,” one might
receive a more accurate representation in the linear pro-
gression18,20 of change in a animal’s status.
For our study, we hypothesized that there would be a
significant difference in CMI responses at the screening
visit versus the start of study visit for CMIs designed to
assess pain and mobility in dogs with osteoarthritis.
Additionally, we hypothesized that there would be a
significant difference in responses under conditions of
dependent interviewing, compared to independent inter-
viewing, when assessing dogs with osteoarthritis during
a clinical study. Further, we hypothesized that depen-
dent interviewing would lessen the placebo effect, and
increase treatment effects.
The aims of this study were:
1 To compare different CMI scores at screening (Day
7) and Day 0 (baseline measures).
2 To compare CMI scores using independent and
dependent interviewing techniques when using the
Canine Brief Pain Inventory (CBPI) and the Client-
Specific Outcome Measures (CSOM).
3 To compare the influence of dependent interviewing
on scores in the placebo versus active treatment
groups.
Methods and Materials
Data were included from dogs participating in 2 studies con-
ducted at the North Carolina State University College of Veteri-
nary Medicine (NCSU-CVM) investigating the use of a novel
therapeutic for the treatment of osteoarthritis-associated pain.
Both studies (A21 and B) were randomized, double masked, pla-
cebo-controlled proof of principle pilot studies with parallel treat-
ment groups. The Institutional Animal Care and Use Committee
(IACUC) approved both studies (IACUC #12-149-O), and in all
cases owners signed a written consent form following a detailed
verbal explanation of the study protocol. Studies were conducted
between May 2013 and November 2014.
Study Population
Data were prospectively collected during 2 separate studies eval-
uating 2 different populations of dogs, study A and study B. Eval-
uation of independent versus dependent interviewing techniques
was done using data collected from study A and evaluation of
baseline stability was done using data collected from both study A
and study B.
In study A, as previously reported,21 following 81 initial
enquires, 37 dogs were screened, and 26 entered the study with 25
completing the 28-day study. One dog was withdrawn after the
Day 14 assessment, because of a cruciate ligament rupture. The
flow of dogs through the study is shown in Figure 1. Data from
study A were used for evaluation of baseline stability, as well as to
assess independent versus dependent interviewing techniques.
In study B, after 101 initial enquires, 36 dogs were screened,
and 26 entered the study with all 26 dogs completing the screening
(Day 7) and the study Day 0 assessments. Data from study B
were used in the assessment of baseline stability, together with
data from study A. The flow of dogs through study B is shown in
Figure 2. No independent/dependent interviewing data were avail-
able from study B.
Dogs in both studies were randomized to receive the drug or
placebo on Day 0 using a computer-deriveda randomization sched-
ule. The randomization schedule and the key were held by the
NCSU pharmacy and not disclosed to investigators until comple-
tion of the statistical analysis.
Inclusion Criteria
To be eligible for either study, dogs were required to be greater
than 1 year old, ≥15 kg, have owner-rated mobility impairment,
and at least one appendicular joint or axial skeleton area that was
considered painful on orthopedic exam and where radiographs
showed the presence of osteoarthritis (OA), as previously described
in detail.21 Dogs were required to be in generally good health and
not be currently receiving any anti-inflammatory medications
(NSAIDs), if the dogs were currently on NSAIDs, a 2-week with-
drawal period was required before study entry. Other analgesics
(eg, amantadine, gabapentin, tramadol) were permitted only if
pain was still present, the dog had been on the medication(s) for
at least 3 weeks and the treatment regimen could be continued
throughout the trial, otherwise a 2-week withdrawal period was
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required before study entry. Dogs were required to be either not
receiving nutritional supplements, or have been on them for at
least 6 weeks before the start of the study and continue them
throughout the study. If dogs were considered to be mobility
impaired, but no OA was detected radiographically, or if they had
OA but the impairment in mobility was not sufficient, they were
not enrolled. Other exclusion criteria included known or suspected
presence of any of the following conditions: clinically significant
cardiovascular disease; severe dental disease; neurological disease,
renal disease; liver disease (ALT levels of up to twice the upper
normal value and AlkPhos levels of up to 4 times the upper nor-
mal value were considered acceptable in the absence of other signs
of liver disease); chronic pulmonary disease; infectious disease;
immune-mediated disease; neoplasia; urinary tract infection;
hypothyroidism (unless well controlled); diabetes mellitus; skin dis-
ease of the foot; obesity (8 or 9 of the 1–9 Body Condition Score
Scale22). Particular attention was given to ruling out neurological
disease through a comprehensive neurological evaluation. Addi-
tionally, owners had to agree to not change the management of
dogs for the period of the study, and owners were required to have
a stable lifestyle for the duration of the study (eg, no planned
house moves, vacations, relationship changes, or new pets).
Study Protocol
Study A was conducted over a 35-day period with outcome
measures gathered on Day 7, Day 0, Day 14 and Day 28. On
Day 7 and Day 0 (baseline period) the owners completed 4
Fig 1. Study A Dog Selection and Enrollment Algorithm. Enrolled dogs were enrolled in either the treatment group with antinerve
growth factor antibody (NV-01) or the placebo group. Data were collected to compare baseline variability, dependent, and independent
interviewing techniques.
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CMI’s (Canine Brief Pain Inventory [CBPI], Liverpool
Osteoarthritis in Dogs Index [LOAD], Helsinki Chronic Pain
Index [HCPI] and Client-Specific Outcome Measures [CSOM])
using only independent interviewing techniques, to establish a
baseline for each dog. On Day 0, dogs were randomized to receive
either the antinerve growth factor antibody (NV-01), or placebo.
Thirteen dogs were administered NV-01 at a dose of 200 lg/kg of
a 2 mg/mL solution IV over a 1-min period through an intra-
venous 20-gage catheter.
Thirteen dogs were administered a placebo (normal saline),
administered IV at a volume equivalent to the dose of NV-01. The
dispensing of drug or placebo was performed by NCSU pharmacy,
with all other personnel involved in the collection of data masked
to the administration until completion of the statistical analysis.
Pharmacy personnel prepared unmarked syringes for each dog
with the barrel covered in opaque tape. Testing before starting the
study indicated there was no appreciable difference between the
feel of injecting saline versus NV-01 through a 20-gage catheter, to
ensure complete masking.
At Day 14 and Day 28 owners also completed all CMIs (inde-
pendent interviewing). Once completed, owners were represented
with the CSOM and the CBPI CMIs, in sequence, and for each
one, they were shown the answers from the previous visit and
asked to complete these CMIs again (dependent interviewing).
Study B had a very similar initial design, with screening being
performed 7 days before study entry. In this study, baseline CMI
data for the CSOM, CBPI, LOAD and HCPI were collected at
Day 7 and Day 0. The owners completed these 4 CMI’s using
only independent interviewing techniques. Treatments were again
administered on Day 0, using the same drug and placebo, but they
were administered subcutaneously.
Clinical Metrology Instruments
All CMI’s were completed by the same owner at all visits, and
owners were directed to base their answers on their observations
of the preceding 7 days. The owners completed the CMI’s while
sitting or standing (as they preferred), in a standard consulting
room. All CMI’s were printed using standardized paper.b At each
time point, they were presented with each CMI sequentially, and
requested to complete the CMI with basic instructions explained
to them in a neutral tone of voice using a standard script. Once
completed, the next CMI was handed to them. CMI’s were always
presented in the following order: CBPI; LOAD; HCPI; CSOM.
Owners completed the CMI’s while their dog was being examined
in a separate room. Only complete CMIs were considered valid.
The CBPI14,23 is a 2-part instrument assessing pain severity and
pain interference. The pain severity score (CBPI pain) is the arith-
metic mean of 4 items scored on an 11-point (0–10) numerical
scale with higher scores correlating to increased level of pain, and
the pain interference score (CBPI interference) is the mean of 6
items similarly scored, with higher scores indicating increased pain
leading to greater interference with daily activity.
The LOAD13,24 is a 13-item instrument with all items reported
on a 5-point Likert-type scale. Each item is scored 0–4, and the
item scores are summed to give an overall instrument score, with
increased scores indicating increased abnormalities seen in the
dog’s behavior, mobility, and exercise levels.
The HCPI25 is a CMI with a total of 11 questions regarding a
activity, behavior, and mood. Each question was evaluated using a
Likert-type scale. Each item was scored 0–4, with higher scores
indicating increased pain and was summed to give an overall
instrument score.
The CSOM15 is a CMI that follows 3 activities that are deter-
mined to be impaired and are unique to the individual dog. It is
modeled after the Cincinnati Orthopedic Disability Index
(CODI).26 The CSOM was constructed by a single study investiga-
tor (BC) for each case as previously described.15 At each time
point, the difficulty performing each of the 3 activities was scored
on a 0–4 scale: 0 = No Problem, 1 = Mildly Problematic,
2 = Moderately Problematic, 3 = Severely Problematic, and
4 = Impossible. The total CSOM score represented the sum of
scores for individual activities.
Statistical Analysis
Data collected from both studies were powered in a similar
manner, as pilot studies, as previously described.21 Two different
approaches were utilized in comparing the agreement of the
CMI scores between the screening (Day 7) and Day 0 from
studies A and B combined. First, average scores were compared
to investigate the presence of a systematic bias in the answers,
by plotting mean scores for each time point (combining both
treatment and placebo groups)  1 standard error and also more
formally using the Wilcoxon signed-rank tests.c Next, the extent
of agreement between screening (Day 7) and Day 0 from indi-
vidual responses were evaluated using agreement plots and intra-
class correlation coefficients (ICCs). Agreement plots included
the individual values, the regression line and also the 45-degree
lines. Statistically, the agreement was summarized using the
ICCs.
For the second aim of this study, dependent interviewing and
independent interviewing CSOM, CBPI pain, and CBPI interfer-
ence scores were compared in a similar fashion to the baseline
scores. The CSOM, CBPI pain, and CBPI interference scores for
Fig 2. Study B Dog Selection and Enrollment Algorithm. Data
were collected only to compare baseline variability.
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Day 14 and Day 28, were evaluated by plotting mean scores for
each time point (combining both treatment and placebo groups) 
1 standard error. To formally test if the mean scores were signifi-
cantly different, the Wilcoxon signed-rank test was used. Agree-
ment plots were created and ICCs calculated.
For the third aim of the study, treatment effects were analyzed
using the Wilcoxon rank-sum test to determine if there was a sig-
nificant difference between the treatment and placebo groups,
using either the dependent or independent interviewing techniques.
In addition, standardized effect sizes were calculated to compare
the results from the dependent and independent interviewing tech-
niques.
Results
Variability in Baseline Data Across Different CMIs
The first portion of the study involved analyzing the
baseline data between the screening (Day 7) and Day
0. For CBPI pain, and HCPI, the average scores for
Day 0 were higher (greater impairment) than the Day
7 average. The LOAD showed a smaller increase
from Day 7 to Day 0. The CBPI interference and
CSOM total showed an average decrease (less impair-
ment) between screening (Day 7) and Day 0. There
was a significant difference between the average scores
on Day 7 and Day 0 for CSOM Total (P = .036),
but not for the CBPI measures (CBPI Pain P = .29,
CBPI Interference P = .32), LOAD (P = .67), or HCPI
(P = .27).
Graphical evaluation of the agreement for CBPI pain,
CBPI interference, LOAD, and HCPI indicated visually
good agreement, given that the regression and 45-degree
lines intersect, and the 45-degree lines overlap with the
95% confidence limits for the regression lines (Fig 3).
For CSOM, the regression line lies entirely below the
45-degree line, suggesting that the Day 7 values tend
to be higher (greater impairment) than the correspond-
ing Day 0 values. However, the 45-degree line for
CSOM does barely intersect with the 95% confidence
limits for the regression line, indicating that the differ-
ence is not statistically significant. The best visual agree-
ment is for the LOAD.
The estimates and corresponding 95% confidence
intervals for the intraclass correlation coefficients were
then evaluated. These showed strong agreement for
CBPI pain (ICC = 0.79, 95% confidence 0.64–0.88),
CBPI interference (ICC = 0.76, 95% confidence 0.59–
0.87), and CSOM (ICC = 0.76, 95% confidence 0.59–
0.86), and almost perfect agreement for HCPI
(ICC = 0.83, 95% confidence 0.70–0.90) and LOAD
(ICC = 0.89, 95% confidence 0.81–0.94), with the best
agreement being seen for the LOAD.
Influence of Independent and Dependent Interviewing
Techniques on CMI Scores
For the CBPI pain (Day 14 P = .33; Day 28 P = .09),
CBPI interference (Day 14 P = .28; Day 28 P = .08), and
CSOM Total (Day 14 P = .42; Day 28 P = 1.0), there
were no significant differences in the average values
between the independent and dependent answers.
Agreement of Independent and Dependent CMI Scores
Graphical evaluation of the agreement between inde-
pendent and dependent interviewing CMI scores
showed good agreement at both Day 14 and Day 28
across the CBPI pain (Fig 4), CBPI interference (Fig 5)
and CSOM (Fig 6). Additionally the ICC estimates, as
well as the 95% confidence intervals, showed almost
perfect agreement for all CMIs; CBPI Pain (Day 14
ICC = 0.98, 95% confidence 0.95–0.99; Day 28
ICC = 0.98, 95% confidence 0.95–0.99), CBPI Interfer-
ence (Day 14 ICC = 0.97, 95% confidence 0.93–0.99;
Day 28 ICC = 0.97, 95% confidence 0.94–0.99), and
CSOM (Day 14 ICC = 0.91, 95% confidence 0.79–0.96;
Day 28 ICC = 0.92, 95% confidence 0.81–0.97).
Evaluation of Treatment Effects Using Dependent and
Independent Interviewing
The placebo and treatment responses for both the
dependent and independent interviewing technique were
evaluated. Data were graphed, and responses from the
surveys completed with dependent interviewing showed
greater improvement (a larger reduction in the average
CMI scores) compared to those completed with inde-
pendent interviewing techniques. This difference
appeared more pronounced for the treatment group
than the placebo group (Fig 7) in all 3 CMIs.
When the change in CMI scores between Day 0 and
Day 14, and Day 0 and Day 28 was compared between
the treatment and placebo group, the significance of the
treatment effect did not change, but P-values were smal-
ler, CBPI Pain (Day 0–14 InD P = .23 and DI P = .16;
Day 0–28 InD P = .21 and DI P = .11), CBPI Interfer-
ence (Day 0–14 InD P = .21 and DI P = .11; Day 0–28
InD P = .30 and DI P = .20), and CSOM (Day 0–14
InD P = .04 and DI P = .03; Day 0–28 InD P = .009
and DI P = .009).
Finally, the between group differences for the inde-
pendent and dependent interviewing techniques were
compared by looking at the standardized effect sizes,
CBPI Pain (Day 0–14 InD 0.57 and DI 0.71; Day 0–28
InD 0.46 and DI 0.65), CBPI Interference (Day 0–14
InD 0.72 and DI 0.87; Day 0–28 InD 0.40 and DI
0.54), and CSOM (Day 0–14 InD 0.86 and DI 0.91;
Day 0–28 InD 1.2 and DI 1.2). In general, the treat-
ment effect sizes were larger for the dependent inter-
viewing technique, except for the CSOM Total at
Day 28.
Discussion
We identified baseline variability in CSOM, CBPI,
LOAD, and HCPI scores when measured 7 days apart
with no intervening treatment, however, the scores at
the 2 baseline time points were not statistically signifi-
cantly different, rejecting our hypothesis. The direction
of shift in baseline scores was not consistent across all
the CMIs, with the best agreement in baseline scores
being found for the LOAD CMI. Overall, we found
good agreement between dependent interviewing and
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Fig 3. CMI’s Baseline Agreement, comparing regression line and 45-degree line. Day 7 CMI scores, on the x-axis, are plotted against
the Day 0 CMI scores (y axis) to determine agreement, with 95% confidence limits represented by gray shading. (A) CBPI pain mean base-
line scores (B). CSOM total mean baseline scores (C). CBPI interference mean baseline scores (D). LOAD mean baseline scores (E). HCPI
mean baseline scores.
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independent interviewing, and no statistically significant
difference between scores collected under the 2 inter-
viewing conditions, leading us to again reject our
hypothesis. These data suggest that overall, neither
interviewing technique will provide statistically different
answers and both appear to be appropriate to use in
the clinical setting. Finally, our data supported our final
hypothesis as we found that the use of dependent inter-
viewing provided, on average, lower CMI scores, a
higher treatment effect, and a higher effect size. By
using dependent interviewing techniques, it could be
possible to increase the treatment effect and effect size,
Fig 4. Independent and dependent interviewing CBPI pain scores at Day 14 (A) and at Day 28 (B). The CBPI-independent pain scores,
on the x-axis, are plotted against the CBPI-dependent pain scores (y axis), with 95% confidence limits represented by gray shading.
Fig 5. Independent and dependent interviewing CBPI interference scores at Day 14 (A) and at Day 28 (B). The CBPI independent inter-
ference scores, on the x-axis, are plotted against the CBPI dependent interference scores (y axis), with 95% confidence limits represented
by gray shading.
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therefore increasing the power of the study through
minimal change to study design.
Our first aim was to evaluate baseline variability in
CMI scores collected during a 7-day interval, with no
treatment having been administered. We had expected
that screening CMI scores would decrease between the
first (Day 7) and second (Day 0) visit because of the
faking bad bias, previously reported by Choi and
Aday.3,12 This appeared to occur for CBPI interference
and CSOM Total, with scores indicating significantly
less impairment on Day 0 compared to the earlier Day
7, but the opposite was seen for the CBPI pain,
LOAD and the HCPI, with the respondent’s CMI
scores increasing (greater pain and impairment) between
Day 7 and Day 0.
A decrease in severity (disability) was expected
because of several possible reasons. As discussed previ-
ously, the Faking Bad bias may be part of the respon-
dents’ discrepancies in the baseline CMI scores; owners
may alter their CMI scores (reporting increased pain
and impairment) to be enrolled in a study at Day 7.
Additionally, the concept of regression to the mean has
been discussed27 where dogs are recruited to a clinical
study when the clinical signs are obvious, and natural
variation in the disease causes them to become better as
the study starts. These 2 phenomena are likely responsi-
ble for the generally expected lower scores at a second
baseline measurement.
The CBPI interference and CSOM Total CMI results
were consistent with our hypothesis and previously
reported data. Between Day 7 and Day 0, the CSOM
scores significantly decreased in severity. As well as the
possible explanations of faking bad and regression to
the mean, the CSOM may suffer from another bias.
The CSOM uses 3 items tailored to each animal, that
the owners are asked to follow and assess. At Day 7,
owners decide on the activity, and rate the difficulty the
pet has performing the activity. They then return home,
and evaluate the activity. This increased attention to the
activity may lead them to realize the pet is not actually
as impaired performing the activity as they initially
thought, whereas all other CMIs are standardized ques-
tionnaires collected using a numeric scale at the time of
presentation.
Baseline variability (test-retest reliability) for LOAD,
CBPI pain, and HCPI have been previously
described,14,24,25 and all have shown a decrease in CMI
scores between the screening (Day 7) and the start of
a clinical trial (Day 0), indicating a systemic bias within
the baseline screening. However, unlike previous
work24,27 our findings showed only the CBPI interfer-
ence and CSOM CMI’s displayed this trend. All other
CMI’s (CBPI pain, LOAD, and the HCPI) showed an
increase in CMI scores when comparing Day 7 to
Day 0 (an increased impairment). This may be caused
by a bias called the recall bias or rumination. Recall
bias28 or rumination could cause owners to increase
importance of major events or experiences during the
clinical trial leading to an alteration of their retest
answers. Owners could overinterpret their pet’s behav-
ior, causing an increased bias and overrepresentation of
their pet’s pain and disability.
When evaluating baseline agreement between each
CMI, it was noted that the LOAD questionnaire had
the best agreement and most consistent results, when
comparing Day 7 to Day 0, and may indicate the
LOAD is inherently the most stable CMI. The ICC for
LOAD found in the current study was identical to the
ICC reported by Hercock et al.24 evaluating dogs with
osteoarthritis, confirming its inherent baseline stability.
Fig 6. Independent and dependent interviewing CSOM scores at Day 14 (A) and at Day 28 (B). The CSOM independent scores, on the
x-axis, are plotted against the CSOM dependent scores (y axis), with 95% confidence limits represented by gray shading.
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Although statistically not different, the variability in
baseline scores in all the CMIs suggests that researchers
using these instruments should take this into considera-
tion when deciding which baseline time point to use
when using “change from baseline” as the primary out-
come measure.14
Although there was no statistical difference between
the 2 survey techniques (independent and dependent
interviewing), an interesting pattern was found with a
consistent decrease in CMI scores across both the pla-
cebo and treatment groups, most pronounced in the
treatment group, when using the dependent interviewing
technique versus the independent interviewing tech-
nique. This phenomenon was also shown within the US
Census Bureau’s Survey Income and Program Participa-
tion (SIPP), where using independent interviewing
resulted in increased variability in answers between 2
time points (seam bias) during the longitudinal study,
compared to dependent interviewing techniques.29,30 As
a result of this research and the inherent forms of bias
presumed to be associated with independent interview-
ing, the US Census Bureau adapted the dependent
interviewing techniques in 2004.16,18
We also found that the answers from the dependent
interviewing technique showed a greater treatment effect
and effect sizes, compared to the independent interview-
ing technique. These are very interesting findings, and
the implications for clinical study design and power are
significant. Previous reported methods to increase treat-
ment effects include increasing sample size, reducing
measurement error, and raising the alpha level.31 How-
ever, increasing sample size has proven to be costly,
and raising the alpha level is not recommended. Using
dependent interviewing techniques could increase the
treatment effect and effect size, therefore increasing the
power of the study through minimal change to study
design and no extra cost. However, our results need to
be replicated before this approach can be strongly rec-
ommended.
We are not aware of any work in veterinary medicine
that compares the 2 interviewing approaches. From our
data, we cannot conclude whether the independent or
dependent interviewing technique provided more accu-
rate results, but given that the difference between the 2
sets of data were more pronounced for the treatment
group, it is tempting to think that dependent interviewing
Fig 7. Graphical plots of CMI mean scores over time, showing placebo independent interviewing, placebo dependent interviewing, treat-
ment group independent interviewing, and treatment group dependent interviewing. These plots show demonstrate consistently lower pain
scores associated with dependent interviewing when compared to independent interviewing. (A) CBPI pain scores (B) CBPI interference
scores (C) CSOM total scores.
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may give a more accurate representation of pain and
mobility. Further studies should evaluate the 2 tech-
niques against objective measures of mobility and lame-
ness.
Summary
We identified some baseline variability in CSOM,
CBPI, LOAD, and HCPI scores when measured 7 days
apart with no intervening treatment, and the direction
of shift in baseline scores was inconsistent across all the
CMIs, with the best agreement in baseline scores being
found for the LOAD CMI, and the least good for the
CSOM CMI. Overall, we found good agreement
between dependent interviewing and independent inter-
viewing, however, the use of dependent interviewing
provided, on average, lower CMI scores, a higher treat-
ment effect, and a higher effect size.
Further research needs to be conducted to determine
if these results can be replicated, particularly across a
larger sample size and longer timeframe.
Footnotes
a 75 g/m2 Husky copy white 92 paper
b Research Randomizer Copyright © 1997-2015 by Geoffrey C.
Urbaniak and Scott Plous
c SAS 9.4 software SAS Institute, Cary, NC, USA
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